NQO1 has attracted much attention as a potential target for the treatment of cancer because it has been shown to be frequently expressed at much higher levels in tumors, mainly in lung tumors, relative to adjacent non-neoplastic tissue regions. The gene discussed is NQO1; the disease is cancer.